Catalyst Wire Dossier Catalyst Wire Dossier

Stelara (ustekinumab)

ustekinumab · Janssen Biotech, Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Stelara (ustekinumab), covering 2016-05-25 to 2024-11-15. Get the full timeline:

Most recent: FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)

See pricing